Population-level influence of rheumatoid arthritis on mortality and recent trends: A multiple cause-of-death analysis in France, 1970-2002

Journal of Rheumatology

Volumn 35, Issue 10, 2008, Pages 1950-1957

  Ziadé, Nelly ^a   Jougla, Eric ^b   Coste, Joel ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c NONE   (France)

Author keywords

Death Certificates; France; Mortality; Rheumatoid arthritis; Vital statistics

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH CERTIFICATE; DECUBITUS; ENDOCRINE DISEASE; FEMALE; FRANCE; HUMAN; INFANT; INJURY; INTERNATIONAL CLASSIFICATION OF DISEASES; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POISSON DISTRIBUTION; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CAUSE OF DEATH; DEATH CERTIFICATES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED;

EID: 54949149849     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269-81.
2. Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994;33:735-9.
3. Sokka T. Work disability in early rheumatoid arthritis. Clin Exp Rheumatol 2003;5 Suppl 31:71-4.
4. Pincus T. Long-term outcomes in rheumatoid arthritis. Br J Rheumatol 1995;34 Suppl 2:59-73.
5. Goodson N, Marks J, Lunt M, Symmons D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005;64:1595-601.
6. Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A. Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol 2004;33:221-7.
7. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8.
8. Mikuls TR, Saag KG, Criswell LA, et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study. Ann Rheum Dis 2002;61:994-9.
9. Hakoda M, Oiwa H, Kasagi F, et al. Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study. Ann Rheum Dis 2005;64:1451-5.
10. Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998;25:1072-7.
11. Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE. Therapeutic strategies in rheumatoid arthritis over a 40-year period. J Rheumatol 2004;31:2366-73.
12. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.
13. Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
14. O'Dell JR, Haire CE, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996 16;334:1287-91.
15. Fautrel B, Constantin A, Morel J, et al. Recommendations of the French Society for Rheumatology. TNF-alpha antagonist therapy in rheumatoid arthritis. Joint Bone Spine 2006;73:433-41.
16. Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45.
17. Emery P, Reginster JY, Appelboom T, et al. WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. Rheumatology Oxford 2001;40:699-702.
18. Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996;39:713-22.
19. Carter H, Chevallier J, Ghoussoub K, Paolaggi JB. Surveys of the epidemiological team of the French Rheumatology Society (RESFR) on the prescription of D-penicillamine in the treatment of rheumatoid polyarthritis. Rev Rhum Mal Osteoartic 1986;53:331-9.
20. Le Loët X, Berthelot JM, Cantagrel A, et al. Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis 2006;65:45-50.
21. Sany J, Bourgeois P, Saraux A, et al. Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists. Ann Rheum Dis 2004;63:1235-40.
22. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999;58:11-4.
23. Krishnan E, Lingala VB, Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004;110:1774-9.
24. Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol 2002;29:906-12.
25. Ward MM. Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? Arthritis Rheum 2001;44:1467-9.
26. Lenfant C, Friedman L, Thom T. Fifty years of death certificates: the Framingham Heart Study. Ann Intern Med 1998;129:1066-7.
27. Laakso M, Isomaki H, Mutru O, Koota K. Death certificate and mortality in rheumatoid arthritis. Scand J Rheumatol 1986;15:129-33.
28. Iribarren C, Crow RS, Hannan PJ, Jacobs DR Jr, Luepker RV. Validation of death certificate diagnosis of out-of-hospital sudden cardiac death. Am J Cardiol 1998;82:50-3.
29. Ruzicka LT, Lopez AD. The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q 1990;43:249-58.
30. Roberts SE, Goldacre MJ. Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study. BMJ 2003;327:771-5.
31. Redelings MD, Sorvillo F, Simon P. A comparison of underlying cause and multiple causes of death: US vital statistics, 2000-2001. Epidemiology 2006;17:100-3.
32. Coste J, Jougla E. Mortality from rheumatoid arthritis in France, 1970-1990. Int J Epidemiol 1994;23:545-52.
33. Pavillon G, Laurent F. Certification et codification des causes médicales de décès. Bulletin Epidémiologique Hebdomadaire 2003;30:134-8.
34. Pavillon G, Boileau J, Renaud G, Lefevre H, Jougla E. Conséquences des changements de codage des causes médicales de décès sur les données nationales de mortalité en France, à partir de l'année 2000. Bull Epidemiol Hebdomadaire 2005;4:13-6.
35. Statistics Canada. Comparability of ICD-10 and ICD-9 for mortality statistics in Canada [monograph. Internet]. Ottawa: Statistics Canada; 2005. Available from: http://www.statcan.ca/bsolc?catno=84-548-X&CHROPG=1
36. Rodriguez C. Poisson models for count data [monograph]. 2007. Available from: data.princeton.edu/wws509/notes/c4.pdf
37. Wicks IP, Moore J, Fleming A. Australian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data. Ann Rheum Dis 1988;47:563-9.
38. Jougla E, Papoz L, Balkau B, Simon D, Vauzelle-Kervroedan F, Hatton F. Analysis of diabetes-related mortality in France (1970-1987) from multiple causes of death. Diabete Metab 1991;17:337-45.
39. Israel RA, Rosenberg HM, Curtin LR. Analytical potential for multiple cause-of-death data. Am J Epidemiol 1986;124:161-79.
40. Welsing PM, Fransen J, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005;52:2616-24.
41. Hochberg MC. Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982. Semin Arthritis Rheum 1990;19:294-302.
42. Doran MF, Pond GR, Crowson CS, O'Fallon WM, Gabriel SE. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002;46:625-31.
43. Silman AJ. Has the incidence of rheumatoid arthritis declined in the United Kingdom? Br J Rheumatol 1988;27:77-9.
44. Symmons D, Turner G, Webb R, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology Oxford 2002;41:793-800.
45. Kahn MF. Can we estimate the incidence, prevalence, and outcomes of rheumatoid arthritis in France? Joint Bone Spine 2004;71:95-7.
46. van der Heijde DM, van Riel PL, van Leeuwen MA, van 't Hof MA, van Rijswijk MH, van de Putte LB. Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis. J Rheumatol 1991;18:1285-9.
47. Ferraccioli GF, Salaffi F, Troise-Rioda W, Bartoli E. The Chronic Arthritis Systemic Index (CASI). Clin Exp Rheumatol 1994;12:241-7.
48. Coste J, Bernardin E, Jougla E. Patterns of mortality and their changes in France (1968-99): insights into the structure of diseases leading to death and epidemiological transition in an industrialised country. J Epidemiol Community Health 2006;60:945-55.
49. Nicola PJ, Crowson CS, Maradit-Kremers H, et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006;54:60-7.
50. Robertson C, Boyle P. Age-period-cohort models of chronic disease rates. II: Graphical approaches. Stat Med 1998;17:1325-39.
51. Swift B, West K. Death certification: an audit of practice entering the 21st century. J Clin Pathol 2002;55:275-9.
52. Lindahl BI. The causal sequence on death certificates: errors affecting the reliability of mortality statistics for rheumatoid arthritis. J Chron Dis 1985;38:47-57.
53. Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand J Rheumatol 1981;10:301-6.